Alpha-GPC: Benefits, Dosage, Contraindications
Other name(s)
a:0:{}
Family or group:
Psuedovitamins
Indications
Rating methodology
EFSA approval.
Alzheimer's Disease ✪✪✪✪✪
The efficacy of Alpha-GPC in the treatment of Alzheimer's disease is promising. A meta-analysis of three moderate-sized clinical studies shows that a daily dose of 1200 mg of Alpha-GPC over six months improves cognitive functions, evaluated by the Mini-Mental State Examination (MMSE), compared to a placebo. Moreover, the combination of Alpha-GPC with donepezil (a drug mainly used in the treatment of Alzheimer's disease) over two years demonstrated an improvement in cognitive functions, a reduction in behavioral symptoms, and enhanced functional abilities, compared to treatment with donepezil alone.
Posologie
Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial
Properties
Neurological
Alpha-GPC is known for its beneficial effects on dementia and the improvement of memory and learning. This compound increases plasma levels of choline, thus promoting the production of acetylcholine and phosphatidylcholine, essential for proper neuronal functioning. As a precursor to membrane phospholipids and glycerolipids, Alpha-GPC can enhance the fluidity of neuronal membranes, thereby optimizing nerve cell function. Its cholinergic effects are also recognized for counteracting memory and attention deficiencies induced by anticholinergic drugs such as scopolamine.
Usages associés
A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia
Effect of choline-containing phospholipids on brain cholinergic transporters in the rat
Safety dosage
Adult: 1200 mg
Alpha-GPC is most commonly used at a dose of 400 mg three times a day for a period of up to six months.
Interactions
Médicaments
Scopolamine: moderate interaction
Alpha-GPC may partially limit the effects of scopolamine on memory and attention impairment.